Lorraine E. Sulick is a notable inventor based in Scotch Plains, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of assays for alpha-amylase. With a total of two patents to her name, her work has implications in medical diagnostics and enzymatic reactions.

Latest Patents

Lorraine's latest patents include a method for an alpha-amylase assay and substrates for use therein. This innovative approach utilizes a maltodextrin phosphorylase limit dextrin in the presence of maltodextrin phosphorylase and inorganic phosphate. The substrate is designed for alpha-amylase, initiating a series of enzymatic reactions that result in a chromogen response. This response can be used to measure the concentration of alpha-amylase in body fluids. Additionally, a novel limit dextrin and its preparation are described in her patents.

Career Highlights

Throughout her career, Lorraine has worked with reputable companies such as Cooper Biomedical, Inc. and Worthington Biochemical Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in biochemical research.

Collaborations

Lorraine has collaborated with notable colleagues, including Paul T. Nix and Rebecca D. Goldfarb. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Lorraine E. Sulick's contributions to the field of alpha-amylase assays highlight her innovative spirit and dedication to advancing biochemistry. Her patents and collaborations reflect her commitment to improving diagnostic methods and understanding enzymatic processes.